Remote monitoring for patients with, or at risk of diabetes
DBm-Health is a patient to clinician system that helps health care professionals manage patients with diabetes or at risk of diabetes, and promotes self-care.
It is ideally suited to patients needing additional support to maintain safe blood glucose levels.
The need for safe remote monitoring during the COVID-19 pandemic
The COVID-19 pandemic has increased the need for digital technologies to help clinicians manage their patients remotely, reducing the risk to individuals who are particularly vulnerable to COVID-19 and are advised to shield during the pandemic.
Benefits
Patient communication
Frequent monitoring of readings and in-app messaging can facilitate improved communication and oversight.
Increased service capacity
Complex cases can be managed more efficiently, freeing up capacity for more patients without increasing resources.
Improved adherence
Easy-to-use apps can lead to more comprehensive reporting of blood glucose levels.
Improved reliability
Replaces paper-based processes which are associated with poor data reliability.
Faster audit
System reports replace time-consuming manual audit processes.
Support for self-monitoring
User-friendly displays of historical readings and self-help guides empower patients to self-manage their condition.
DBm-Health is classified as a Medical Device and is registered as such with the UK National Competent Authority (MHRA).
Free smartphone app
Patients can input and share blood glucose readings and other relevant data (i.e. medication taken), and request a callback from their care team.
Clinician's desktop app
Patient lists can be filtered to help prioritise interventions; individual blood glucose readings can be viewed; and messages sent to patients via the app or by SMS.
Self-monitoring for patients
Self-help guides and a record of blood glucose readings in diary and graph format helps patients to actively manage their blood glucose levels.
DBm-Health is intended for adult patients with, or at risk of diabetes needing frequent blood glucose monitoring, including:
- Patients new to insulin treatment needing enhanced diabetes support from their healthcare team
- Cancer patients receiving high dose steroid treatment
- Women with diabetes planning a pregnancy
- Patients with type 1 diabetes not suited to continuous glucose monitoring (CGM)
- Patients with coronavirus at risk of hyperglycaemia
- Patients with type 2 diabetes requiring intensive support
DBm-Health in the news
FAQs
Note: Not all Sensyne Health products are available in all territories, for further information contact head office.
Disclaimer: Sensyne Health are not responsible for external website content.
